References
- Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus Main Proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.).), 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
- Anurag, A., Nem Kumar, J., Neeraj, K., & Giriraj, T. K. (2020). Molecular docking study to identify potential inhibitor of covid-19 main protease enzyme: An in-silico approach. ChemRxiv. https://doi.org/https://doi.org/10.26434/chemrxiv.12170904.v1
- Astuti, I. & Ysrafil, (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome, 14(4), 407–412. https://doi.org/https://doi.org/10.1016/j.dsx.2020.04.020
- Baliga, M. S., Thilakchand, K. R., Rai, M. P., Rao, S., & Venkatesh, P. (2012). Aegle marmelos (L.) Correa (Bael) and its phytochemicals in the treatment and prevention of cancer. Integrative Cancer Therapies, 12(3), 187–196. https://doi.org/https://doi.org/10.1177/1534735412451320
- Borgio, J. F., Alsuwat, H. S., Al Otaibi, W. M., Ibrahim, A. M., Almandil, N. B., Al Asoom, L. I., Salahuddin, M., Kamaraj, B., & AbdulAzeez, S. (2020). State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2. Archives of Medical Science : Ams, 16(3), 508–518. https://doi.org/https://doi.org/10.5114/aoms.2020.94567
- Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet), 395(10223), 507–513. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30211-7
- Chopra, B., Dhingra, A. K., Kapoor, R. P., & Prasad, D. N. (2016). Piperine and its various physicochemical and biological aspects: A review. Open Chemistry Journal, 3(1), 75–96. https://doi.org/https://doi.org/10.2174/1874842201603010075
- Deeki, T. L., Manivannan, S., Upadhyaya, S., & Roy, B. G. (2019). Targeted metabolic profiling of Black turmeric (Curcuma caesia Roxb.). Research Journal of Biotechnology, 14(9), 24–28.
- Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research, 7(1), 11 https://doi.org/https://doi.org/10.1186/s40779-020-00240-0
- Habtemariam, S., Nabavi, S. F., Banach, M., Berindan-Neagoe, I., Sarkar, K., Sil, P. C., & Nabavi, S. M. (2020). Should we try SARS-CoV-2 helicase inhibitors for COVID-19 therapy? Archives of Medical Research, 51(7), 733–735. https://doi.org/https://doi.org/10.1016/j.arcmed.2020.05.024
- Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.052
- Jain, R., Pandey, R., Mahant, R. N., & Rathore, D. S. (2015). A review on medicinal importance of Emblica officinalis. International Journal of Pharmaceutical Sciences and Research, 6(1), 72-84. https://doi.org/https://doi.org/10.13040/IJPSR.0975-8232.6(1).72-84
- Jamkhande, P. G., Suryawanshi, V. A., Kaylankar, T. M., & Patwekar, S. L. (2016). Biological activities of leaves of ethnomedicinal plant, Borassus flabellifer Linn. (Palmyra palm): An antibacterial, antifungal and antioxidant evaluation. Bulletin of Faculty of Pharmacy, Cairo University, 54(1), 59–66. https://doi.org/https://doi.org/10.1016/j.bfopcu.2016.01.002
- Khaerunnisa, S., Kurniawan, H., Awaluddin, R., & Suhartati, S. (2020). Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints, https://doi.org/https://doi.org/10.20944/preprints202003.0226.v1
- Lee, T. W., Cherney, M. M., Liu, J., James, K. E., Powers, J. C., Eltis, L. D., & James, M. N. G. (2007). Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase. Journal of Molecular Biology, 366(3), 916–932. https://doi.org/https://doi.org/10.1016/j.jmb.2006.11.078
- Lu, H. (2020). Drug treatment options for the 2019-new coronavirus (2019-nCoV). BioScience Trends, 14(1), 69–71. https://doi.org/https://doi.org/10.5582/bst.2020.01020
- Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14 < 1639::AID-JCC10 > 3.0.CO;2-B
- Mothay, D., & Ramesh, K. V. (2020). Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock. VirusDisease, 31, 194-199. https://doi.org/https://doi.org/10.1007/s13337-020-00585-z
- Mousavizadeh, L., & Ghasemi, S. (2020). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of Microbiology, Immunology and Infection. https://doi.org/https://doi.org/10.1016/j.jmii.2020.03.022
- Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/https://doi.org/10.1021/acs.jmedchem.5b00104
- Reiner, Ž., Hatamipour, M., Banach, M., Pirro, M., Al-Rasadi, K., Jamialahmadi, T., Radenkovic, D., Montecucco, F., & Sahebkar, A. (2020). Statins and the COVID-19 main protease: In silico evidence on direct interaction. Archives of Medical Science: AMS, 16(3), 490–496. https://doi.org/https://doi.org/10.5114/aoms.2020.94655
- Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020). Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences, 117(21), 11727–11734. https://doi.org/https://doi.org/10.1073/pnas.2003138117
- Sharma, A. D., & Kaur, I. (2020, April). Molecular docking studies on Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection. http://arxiv.org/abs/2004.00217
- Tahir Ul Qamar, M., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10(4), 313–319. https://doi.org/https://doi.org/10.1016/j.jpha.2020.03.009
- Tian, W., Chen, C., Lei, X., Zhao, J., & Liang, J. (2018). CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Research, 46(W1), W363–W367. https://doi.org/https://doi.org/10.1093/nar/gky473
- Venugopal, A., Rinu, K. A., & Joseph, D. (2017). Medicinal properties of black turmeric: A review. Innoriginal International Journal of Science, 4(3), 2–5.
- Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/https://doi.org/10.1038/s41422-020-0282-0
- Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., & Zhu, W. (2020). Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. BioRxiv, https://doi.org/https://doi.org/10.1101/2020.01.27.921627
- Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., Tamamura, H., Fujii, N., & Yamamoto, N. (2004). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochemical and Biophysical Research Communications, 318(3), 719–725. https://doi.org/https://doi.org/10.1016/j.bbrc.2004.04.083
- Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., Zhan, S., Lu, R., Li, H., Tan, W., & Liu, D. (2020). In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 71(15), 732–739. https://doi.org/https://doi.org/10.1093/cid/ciaa237
- Zahedipour, F., Hosseini, S. A., Sathyapalan, T., Majeed, M., Jamialahmadi, T., Al‐Rasadi, K., Banach, M., & Sahebkar, A. (2020). Potential effects of curcumin in the treatment of COVID-19 infection. Phytotherapy Research), 34(11), 2911–2920. https://doi.org/https://doi.org/10.1002/ptr.6738
- Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 588(7836), E6–E6. https://doi.org/https://doi.org/10.1038/s41586-020-2012-7
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017